Method Peptides · Research compound
$15 flat rate on orders under $200.
Tracking is provided when the order ships.
Research reference
Product specifications, research context, and handling information.
PT-141, also known as bremelanotide, is a cyclic peptide studied for activity at melanocortin receptors.
Research examines receptor subtype responses, central signaling, and structure–activity relationships among melanocortin analogs.
PT-141 engages multiple melanocortin receptors. Experimental work evaluates how receptor activation relates to downstream neural and cellular responses, including MC4R-associated signaling.
PT-141 research examines how melanocortin receptor activity relates to neural and behavioral responses. Receptor-subtype comparisons help clarify the contribution of central pathways, including MC4R-associated signaling.
This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.
